Drynaria fortunei
Drynaria fortunei has been studied in 1 paper since 2021: 1 trial in people. The newest paper, Dec 15, 2021: “Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation”.
1 paper studies it5 findingsUpdated
See all 1 papers on drynaria fortunei
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Drynaria fortunei has been demonstrated to significantly improve lipid profiles for elderly PMOP patients.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave drynaria fortunei to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves bone mineral density down: Decreases plasma IL-1β, IL-18, TNF-α, IL-6, IL-8 | Randomized trial12 months | 80 peopleWomenelderlyOlder adults; Postmenopausal women; elderly PMOP patients with hyperlipemia | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Dec 15, 2021 |
What did studies of drynaria fortunei find?
5Studies of drynaria fortunei measured 5 outcomes, among them NOTCH1, NLRP3 inflammasome and plasma IL-1β, IL-18, TNF-α, IL-6, IL-8.
NOTCH1
downin human cells1
1 study
NOTCH1
downin human cells1
Drynaria fortunei decreases NOTCH1 in human cells with SIRT1 expression suppressed.
“Drynaria fortunei had inhibitory effects on NLRP3 inflammasome and Notch1 even when SIRT1 expression was suppressed.”
Cellswith SIRT1 expression suppressedPBMC
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
NLRP3 inflammasome
downin human cells1
1 study
NLRP3 inflammasome
downin human cells1
Drynaria fortunei decreases NLRP3 inflammasome in human cells (PBMC from PMOP patients cultured in vitro).
“Drynaria fortunei suppressed NLRP3 inflammasome and associated cytokines by increasing SIRT1 or decreasing Notch1.”
CellsPBMC from PMOP patients cultured in vitroPBMC
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Plasma IL-1β, IL-18, TNF-α, IL-6, IL-8
downin humans1
1 study
Plasma IL-1β, IL-18, TNF-α, IL-6, IL-8
downin humans1
Drynaria fortunei decreases plasma IL-1β, IL-18, TNF-α, IL-6, IL-8 in humans (relative to control group over 12-month follow-up).
“but were significantly attenuated with Drynaria fortunei administration”
Human trialrelative to control group over 12-month follow-up12 monthsfemalesn = 80
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Bone mineral density
upin humans1
1 study
Bone mineral density
upin humans1
Drynaria fortunei improves bone mineral density in humans (elderly PMOP patients with hyperlipemia).
“Drynaria fortunei effectively improved patients' BMD and lipid profiles.”
Human trialelderly PMOP patients with hyperlipemia12 monthsfemalesn = 80
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Lipid profile
upin humans1
1 study
Lipid profile
upin humans1
Drynaria fortunei improves lipid profile in humans (elderly PMOP patients with hyperlipemia).
“Drynaria fortunei has been demonstrated to significantly improve lipid profiles for elderly PMOP patients.”
Human trialelderly PMOP patients with hyperlipemia12 monthsfemalesn = 80
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology